As of 2024-07-27, the Intrinsic Value of Abbott Laboratories (ABT) is
92.17 USD. This Abbott valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 105.24 USD, the upside of Abbott Laboratories is
%.
The range of the Intrinsic Value is 61.37 - 188.47 USD
92.17 USD
Intrinsic Value
Abbott Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
61.37 - 188.47 |
92.17 |
-12.4% |
| DCF (Growth 10y) |
70.69 - 202.81 |
103.05 |
-2.1% |
| DCF (EBITDA 5y) |
88.11 - 134.59 |
107.26 |
1.9% |
| DCF (EBITDA 10y) |
93.32 - 152.35 |
117.24 |
11.4% |
| Fair Value |
74.77 - 74.77 |
74.77 |
-28.95% |
| P/E |
115.08 - 149.81 |
125.91 |
19.6% |
| EV/EBITDA |
99.87 - 141.62 |
116.61 |
10.8% |
| EPV |
48.63 - 71.93 |
60.28 |
-42.7% |
| DDM - Stable |
27.39 - 104.31 |
65.85 |
-37.4% |
| DDM - Multi |
51.27 - 143.33 |
74.57 |
-29.1% |
Abbott Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
183,078.66 |
| Beta |
0.53 |
| Outstanding shares (mil) |
1,739.63 |
| Enterprise Value (mil) |
191,380.66 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.53% |
| Cost of Debt |
4.34% |
| WACC |
9.09% |